MC Services AG’s Post

We are glad to introduce our upcoming Global Bioprocessing & Bio Technology Summit taking place on the 22nd – 23rd of May 2025 in Berlin, Germany. In a world where every cell holds a secret and is a realm for discovery, the Bioprocessing Summit returns as the catalyst for unraveling the complexities of advanced therapeutic interventions. Join the global biotech conference with experts as they share insights and deliberate on pertinent and trending issues in the industry. Bio Tec Summit is a premier investor conference committed to creating a platform for biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives. While spreading enlightenment on these burning topics, there will be discussions on the application of environmentally conscious and socially responsible practices in the field of Bioprocessing. By examining case studies and drawing insights from lessons learned, the summit aids in shaping the very future we have dared to imagine. International Bioprocessing Summit: Uniting Innovators in Bio-Tech Conference Enjoy uniting Biotech Innovators, where each discovery propels us deeper into the realms of limitless potential. Embark on a journey of discovery at our Global Bioprocessing Summits and Biotech Conferences, where biotech industry leaders converge to explore cutting-edge advancements and foster collaboration. Kindly visit our website for more information about the event: https://lnkd.in/e2jPzdep #Bioprocessing #Biotechnology #pharmaceutical #CW

🔍 Spotlight on #Pharma #Partnerships in #TechBio: Showcasing Pfizer In the ever-evolving world of biotechnology, partnerships are the driving force behind groundbreaking innovations. Pfizer, a global leader in the biopharmaceutical industry, exemplifies this spirit of collaboration. 🌐 Pfizer's TechBio Collaborations Among 115 disclosed partnerships worldwide, Pfizer has strategically focused 32 on the TechBio sector. These alliances underscore Pfizer's commitment to integrating cutting-edge technology with biological research to develop pioneering therapies. 📊 Geographic Distribution of Pfizer's TechBio Partnerships: - 66% with US ventures - 19% with Asia-Pacific ventures - Only 6% with European ventures This distribution highlights Pfizer's strong focus on the US market while recognizing the growing innovation landscapes in Asia-Pacific and Europe. 🔬 Venture Maturity Insight: The average alpha score, which indicates the maturity of Pfizer's TechBio portfolio, is a notable 69.8. This score reflects the advanced development stage and significant potential of the ventures within Pfizer's collaborative network. #drugdiscovery #omics #bioinformatics

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 Merck Life Science 🗞️📰 Merck is making a major investment in the Asia-Pacific region with a new €300 million bioprocessing production center in Daejeon, South Korea💰. 𝘛𝘩𝘪𝘴 𝘪𝘴 𝘵𝘩𝘦 𝘭𝘢𝘳𝘨𝘦𝘴𝘵 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘺𝘦𝘵 𝘣𝘺 𝘔𝘦𝘳𝘤𝘬'𝘴 𝘭𝘪𝘧𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦 𝘣𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘴𝘦𝘤𝘵𝘰𝘳 𝘪𝘯 𝘵𝘩𝘦 𝘢𝘳𝘦𝘢 𝘢𝘯𝘥 𝘳𝘦𝘧𝘭𝘦𝘤𝘵𝘴 𝘵𝘩𝘦 𝘣𝘰𝘰𝘮𝘪𝘯𝘨 𝘣𝘪𝘰𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘦𝘶𝘵𝘪𝘤𝘢𝘭 𝘮𝘢𝘳𝘬𝘦𝘵.👏🏻 𝑻𝒉𝒆 𝒏𝒆𝒘 𝒇𝒂𝒄𝒊𝒍𝒊𝒕𝒚 𝒘𝒊𝒍𝒍 𝒃𝒆 𝒂 𝒐𝒏𝒆-𝒔𝒕𝒐𝒑 𝒔𝒉𝒐𝒑 𝒇𝒐𝒓 𝒃𝒊𝒐𝒑𝒉𝒂𝒓𝒎𝒂 𝒄𝒐𝒎𝒑𝒂𝒏𝒊𝒆𝒔, 𝒐𝒇𝒇𝒆𝒓𝒊𝒏𝒈: ◼️Process development support ◼️Clinical research assistance ◼️Commercial biologics production ◼️Critical biotech products like cell culture media and pre-GMP manufacturing systems This investment is expected to create 300 new jobs by 2028 and will undoubtedly boost the Korean biopharma industry.💼👩🏻⚕️ This is part of Merck's multi-year plan to increase capacity and meet the global demand for essential drugs. With its focus on collaboration, Merck aims to accelerate the development of new therapies for patients. #merck #biotechnology #southkorea #investment #healthcare #lifescience

Revolutionising Drug Discovery: Innovations in Biotech The pharmaceutical landscape is evolving rapidly, driven by technological advancements and innovative approaches. One of the key challenges facing the industry has been the lack of druggable targets for diseases affecting large populations. However, emerging technologies are reshaping drug discovery. This week, we profile 3 startups driving innovation in biotech: Vivodyne, Cytonus Therapeutics and Zafrens. Read more: https://lnkd.in/djAG4DQY Get innovation insights from The FutureList weekly. Subscribe to our newsletter here: https://bit.ly/3DVZexv #biotech #biotechnology #medtech #innovation #drugdiscovery

Virginia Governor Glenn Youngkin has proposed a statewide research network to drive more resources toward biotechnology, life sciences, and pharmaceutical manufacturing—dubbed Virginia’s Research Triangle. The $96.4 million proposal is modeled after North Carolina’s research hub, with a stronger focus on translational work. Youngkin hopes to attract and retain biotech companies and talent in Virginia by offering a lower cost of living and higher quality of life compared to other established research hubs. Find more details in the comments. - #VCCRN #virginiaclinicalresearch #clinicalresearch #clinicaltrial #clinicalresearcherresources #VAresearchtriangle

Here is our analysis of recent corporate venture capital (CVC) trends in pharma. VC funding proves to be a game-changer for the pharmaceutical industry, offering access to innovative solutions, reducing R&D risks, and diversifying pipelines. For early-stage biotech firms, it provides essential funding and validation. Three key findings — read the report for more: 1.     Investments have rebounded following a post-pandemic drop 2.     The boom in digital therapeutics investment is over 3.     Investment in new modalities is eating into capital allocated to small molecules Read more here > https://owy.mn/4hkgz5t #Pharmaceuticals #Biotech #OWHealth

There is an “unprecedented opportunity” for startups in the biopharma space. Dr. Christoph Massner and Sifted have a great article explaining why a mixture of technology innovations and upcoming patent cliffs across Big Pharma mean it is a great time to be in biotech. Ignota Labs are onboarding 4 new projects over the next 24 months, developing them into blockbuster drugs ready for Big Pharma acquisition ahead of this cliff edge. Follow to find out more about how we are using our unique safety AI to find hidden potential from 1,000s of drug projects which have been de-prioritised - speeding up drug discovery by not starting from scratch. #biotech #techbio #aidrugdiscovery #pharmaceuticals #drugdevelopment

Exciting News! BioLink has successfully completed its Series A+ strategic financing round! Led by several top-tier investors, along with continued support from existing shareholders, this round has raised the target funding. This tremendous support underscores the confidence in BioLink's vision and potential for growth. As a professional lifescience company, BioLink is committed to continuously providing customers with high-quality innovative products and solutions. "Link to enable biotechnologies", our vision is to create an efficient, safe, and competitive biopharmaceutical supply chain ecosystem for our customers. This financing round will fuel our efforts in research and development, technological advancement, and international market expansion. We remain committed to our core values of innovation, quality, and customer satisfaction as we continue to tackle challenges and refine our product portfolio. A huge thank you to our investors for their unwavering support, and to our incredible team for their dedication and hard work. Together, we're shaping the future of biotechnology and driving progress in the biopharmaceutical industry. Stay tuned for more updates on our journey! #BioLink #BiotechInnovation #Bioprocessing #InvestmentSuccess https://lnkd.in/gbjRsKDs

We are looking forward to having Renaud JACQUEMART, PhD, MBA back at #BiotechWeekBoston in just over a week for Informa’s Bioprocess International. Renaud is excited to kick off the fall conference season! We are attending to support various clients in biopharmaceuticals, drug delivery, advanced therapies, and biomanufacturing with their search for strategic partners, as well as connect with companies interested in exploring how Omnium can support them in reaching their scientific and commercial goals. About Informa Connect Bioprocess International: The conference will discuss strategies to harness innovative technologies, improve efficiencies, reduce costs for biologics, and much more. The exhibition will include 250+ comprised of global suppliers, CDMOs and CROs that support the entire spectrum of biopharmaceutical development and production. Workshops will feature important topics such as continuous manufacturing, CMC, AI in biomanufacturing, molecular bioprocessing, advanced therapies, and more. Unlock the Future of Bioprocessing https://lnkd.in/dXzjV2w September 23-26, 2024|Hynes Convention Center, Boston, USA #BPI2024 #BiotechweekBoston #Biotechinnovation #Biotech #biotechnology #networking #collaboration #partnership #innovation #biomanufacturing #biologics #drugdelivery #noveldrugs #biopharma #startups #fundraising

Reflecting on the closure of the world’s first commercial biologics plant, once the cradle of the groundbreaking "Orange Marmalade" project, evokes a profound sense of nostalgia and gratitude. Being a part of such a pioneering endeavor has been a privilege. This isn't merely the conclusion of a chapter in industrial achievement; it's the culmination of an era that reshaped the landscape of biotechnology and pharmaceutical manufacturing. "Orange Marmalade" was more than a project; it was a testament to human ingenuity and the relentless pursuit of innovation. The work done here has laid the groundwork for countless advancements and set the standard for what is possible in the realm of biologics. As the lights dim on this historic facility, it's important to remember that the legacy of this plant and its people will continue to illuminate the path forward for the industry. The closure marks a moment of reflection, an opportunity to honor the achievements, the breakthroughs, and the challenges overcome. It's a time to acknowledge the collective effort of all those who were part of this journey—scientists, engineers, technicians, and support staff whose dedication and hard work have left an indelible mark on the world. To have been a part of this esteemed company, to have contributed to its storied history, is a source of immense pride. The end of this era is not just a farewell to a facility but a celebration of its impact, a tribute to the spirit of discovery that drove "Orange Marmalade" from concept to reality. The legacy of this plant, and the work done here, will forever be a beacon of inspiration, urging us to keep pushing the boundaries of what's possible. As we move forward, let's carry the lessons learned and the spirit of innovation with us into the next chapter of biologics and beyond. The end of an era for the first commercial biologics plant is also the beginning of the next; the knowledge and experiences gained here will undoubtedly continue to fuel the next generation of breakthroughs. Forever grateful, looking forward to the future with anticipation and the unwavering belief in the power of science to change the world.#genentech #roche #breakthroughs #GenentechInnovation #BiotechLeaders #HealthcareRevolution #ScienceForABetterLife #BreakingBarriersInBiotech